Azopt

Product manufactured by Alcon Laboratories, Inc.

Application Nr Approved Date Route Status External Links
NDA020816 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Azopt ® (Brinzolamide Ophthalmic Suspension) 1% Is A Carbonic Anhydrase Inhibitor Indicated In The Treatment Of Elevated Intraocular Pressure In Patients With Ocular Hypertension Or Open-Angle Glaucoma. Azopt ® Is A Carbonic Anhydrase Inhibitor Indicated For In The Treatment Of Elevated Intraocular Pressure In Patients With Ocular Hypertension Or Open-Angle Glaucoma ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Brinzolamide BRINZOLAMIDE ZINC3953037

Comments